peptide safety checker

evaluate your peptide supplier in 8 questions. get a safety grade, learn how to read a Certificate of Analysis, and know the red flags.

for educational purposes only. this tool helps you evaluate supplier documentation. it does not endorse or certify any supplier. consult a qualified healthcare professional before using any peptides.

why peptide safety matters

the peptide sourcing landscape ranges from pharmaceutical-grade manufacturers to unregulated vendors with no quality controls. the difference between them is not always obvious from a website or product label. what matters is the documentation behind the product -- specifically, the Certificate of Analysis (COA).

a COA is a report from a testing laboratory that verifies the identity, purity, and safety of a specific batch of peptide. it typically includes HPLC purity analysis, mass spectrometry confirmation, and endotoxin testing. without this document, there is no objective way to know what you have.

this tool walks you through 8 critical quality indicators, one at a time. based on your answers, you will receive a safety grade (A through F) with a detailed breakdown showing exactly where your supplier meets or falls short of quality benchmarks.

safety checker

anatomy of a Certificate of Analysis

click any section on the COA below to learn what to look for and what red flags to watch out for.

red flags to watch for

these warning signs indicate potential quality or safety issues with a peptide supplier. any single red flag warrants caution; multiple red flags together suggest the supplier should be avoided.

frequently asked questions

a COA is a document from a testing laboratory that reports the quality testing results for a specific batch of peptide. it typically includes HPLC purity, mass spectrometry confirmation, endotoxin testing, sterility testing, and batch identification. the COA is the primary tool for verifying peptide quality and safety.

research-grade peptides should be at least 95% pure as measured by HPLC. clinical-grade peptides target 98% or higher. the remaining impurity percentage consists of truncated sequences, deletion peptides, and chemical byproducts from synthesis. purity below 95% increases the risk of unknown contaminants.

third-party testing eliminates conflicts of interest. when a supplier tests their own products, they are grading their own homework. an independent laboratory has no financial incentive to inflate purity numbers or omit unfavorable results. look for labs with ISO 17025 accreditation.

endotoxin testing (the LAL test) detects bacterial cell wall fragments called lipopolysaccharides. these contaminants can cause fever, inflammation, and serious immune reactions when injected. the acceptable limit is typically less than 5 EU/mg for injectable peptides. this test is critical for any peptide intended for injection.

mass spectrometry (MS) confirms the molecular identity of a peptide by measuring its mass-to-charge ratio. while HPLC tells you something is pure, mass spec confirms it is the correct molecule. the observed molecular weight should match the theoretical weight within 0.1%. without MS, you cannot verify that the peptide is what it claims to be.

most reputable suppliers post COAs on their product pages or provide them upon request. ask for a COA specific to your batch/lot number, not a generic document. if a supplier cannot or will not provide a batch-specific COA, that is a significant red flag. some community forums also maintain databases of third-party testing results.

references
  1. United States Pharmacopeia (USP). "General Chapter 621: Chromatography." USP-NF. 2024.
  2. European Pharmacopoeia. "2.2.29 Liquid Chromatography." Ph. Eur. 11th Edition.
  3. United States Pharmacopeia (USP). "General Chapter 85: Bacterial Endotoxins Test." USP-NF. 2024.
  4. International Organization for Standardization. "ISO 17025: General Requirements for the Competence of Testing and Calibration Laboratories." 2017.
  5. FDA. "Guidance for Industry: Analytical Procedures and Methods Validation for Drugs and Biologics." U.S. Food and Drug Administration. 2015.
  6. Verbeke R, et al. "Quality control of synthetic peptides: design and analytical strategies." J Pharm Biomed Anal. 2018;151:176-189.
  7. Aucella F, et al. "Endotoxin contamination and dialysis: a review." J Nephrol. 2003;16(4):492-499.
  8. Rathore AS, Winkle H. "Quality by design for biopharmaceuticals." Nat Biotechnol. 2009;27(1):26-34.

understand the science behind peptide quality

learning peptide chemistry makes you a better evaluator. our courses cover peptide structure, synthesis methods, stability factors, and the science behind every test on a COA.